2018
DOI: 10.1021/acs.orglett.8b00951
|View full text |Cite
|
Sign up to set email alerts
|

[3 + 2]-Cycloaddition of Azaoxyallyl Cations with Hexahydro-1,3,5-triazines: Access to 4-Imidazolidinones

Abstract: A novel base-promoted [3 + 2] cycloaddition reaction of azaoxyallyl cations with hexahydro-1,3,5-triazines has been developed, affording 4-imidazolidinones in moderate to good yields under mild reaction conditions. This simple but efficient protocol features cycloaddition of two in situ formed reactive species in the absence of a transition-metal catalyst.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(23 citation statements)
references
References 42 publications
0
22
0
1
Order By: Relevance
“…In addition, this macrocyclization would lead to the generation of a new chiral center with high stereoselectivity and introduce a nonpeptidic moiety, 4‐imidazolidinone, into the macrocycle. This is a feature that is known to generally improve the intrinsic pharmacokinetic profile while maintaining biological activity …”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…In addition, this macrocyclization would lead to the generation of a new chiral center with high stereoselectivity and introduce a nonpeptidic moiety, 4‐imidazolidinone, into the macrocycle. This is a feature that is known to generally improve the intrinsic pharmacokinetic profile while maintaining biological activity …”
Section: Resultsmentioning
confidence: 98%
“…This approach represents ar are example of conformationally induced amide bond activation that might offer ageneral strategy for the efficient synthesis of 4-imidazolidinone-fused cyclic peptides ( Figure 1). 4-Imidazolidinone is an important structural motif found in many pharmaceuticals and biologically active compounds, [23,24] such as N,N'-methyleno-didemnin A, [25] which is cytotoxic against human colon tumor cells;s piroimidazolidinone,w hich exhibits anticonvulsant activity; [26] Ro 64-6198, an agonist for the nociceptin/orphanin FQ opioid peptide (NOP) receptor; [27] and ML298, as elective inhibitor of phospholipase D (PLD) [28] (Figure 1c).…”
Section: New Cyclization Strategymentioning
confidence: 99%
“…Symmetrical N-substituted 1,3,5-triazinanes have been shown to be useful intermediates in organic synthesis, serving as synthons for the corresponding aldimines, which can be generated in situ for further chemical transformations. [1][2][3][4] 1,3,5-Triazinanes have found practical use as elements of synergistic antimicrobial compositions. 5 However, little information is available on straightforward approaches to the synthesis of unsymmetrically N-substituted 1,3,5-triazinanes.…”
mentioning
confidence: 99%
“…This approach represents a rare example of conformationally induced amide bond activation that might offer a general strategy for the efficient synthesis of 4‐imidazolidinone‐fused cyclic peptides (Figure ). 4‐Imidazolidinone is an important structural motif found in many pharmaceuticals and biologically active compounds, such as N , N′ ‐methyleno‐didemnin A, which is cytotoxic against human colon tumor cells; spiroimidazolidinone, which exhibits anticonvulsant activity; Ro 64‐6198, an agonist for the nociceptin/orphanin FQ opioid peptide (NOP) receptor; and ML298, a selective inhibitor of phospholipase D (PLD) (Figure c).…”
Section: Resultsmentioning
confidence: 99%